SEC Form 4 · accession 0001144204-15-057609
BRAINSTORM CELL THERAPEUTICS INC. · BCLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Chaim Lebovits
Officer — See Remarks
Period of report
Sep 28, 2015
Accepted (ET)
Oct 1, 2015 · 12:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001137883
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.45 | Sep 28, 2015 | A | 369,619 | A | Sep 28, 2015 | Sep 28, 2025 | Common Stock | 369,619 | 369,619 | D |
Explanation of responses
- F1Option vests and becomes exercisable in 12 consecutive, equal monthly installments starting September 28, 2015, until fully vested on August 28, 2015.
Remarks
Chief Executive Officer & President